NEW YORK (GenomeWeb News) – Siemens Healthcare has agreed to a five-year supply, distribution, sales, and service contract with Japanese firm Sysmex, Siemens said today.

The global agreement will cover distribution of a variety of diagnostic tests and coagulation instruments to test and monitor patients using blood thinning medications, Siemens said. The agreement also includes access to automated platelet function testing.

The firms also intend to continue joint product development efforts related to coagulation technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.